Income Statement (TTM)
Sanimed Société Anonyme Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36 | 35 | 44 | 53 | 58 | 63 | 63 | 63 | 61 | 58 | 51 | 44 | 38 | 35 | 34 | 33 |
| Change (%) | -1.41 | 25.12 | 20.08 | 9.46 | 8.64 | 0.12 | 0.12 | -4.17 | -4.35 | -11.77 | -13.34 | -14.70 | -6.75 | -2.93 | -3.81 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 24 | 24 | 27 | 29 | 30 | 30 | 31 | 32 | 33 | 34 | 30 | 26 | 23 | 22 | 21 | 21 |
| Change (%) | 1.79 | 10.00 | 9.09 | 0.85 | 0.84 | 4.27 | 4.09 | 2.15 | 2.10 | -10.83 | -12.14 | -13.62 | -3.85 | -3.97 | -2.68 | |
| % of Revenue | 66.73 | 68.90 | 60.57 | 55.03 | 50.70 | 47.06 | 49.01 | 50.96 | 54.32 | 57.99 | 58.60 | 59.41 | 60.17 | 62.03 | 61.37 | 62.09 |
| Gross Operating Profit | 12 | 11 | 17 | 24 | 29 | 34 | 32 | 31 | 28 | 24 | 21 | 18 | 15 | 13 | 13 | 13 |
| Change (%) | -7.83 | 58.61 | 36.95 | 20.00 | 16.66 | -3.57 | -3.70 | -10.74 | -12.03 | -13.07 | -15.03 | -16.28 | -11.12 | -1.24 | -5.60 | |
| % of Revenue | 33.27 | 31.10 | 39.43 | 44.97 | 49.30 | 52.94 | 50.99 | 49.04 | 45.68 | 42.01 | 41.40 | 40.59 | 39.83 | 37.97 | 38.63 | 37.91 |
| SG&A | 10 | 11 | 12 | 13 | 14 | 14 | 14 | 14 | 13 | 13 | 13 | 13 | 11 | 11 | 11 | 11 |
| Change (%) | 5.68 | 10.71 | 9.67 | 3.29 | 3.19 | -0.50 | -0.50 | -3.53 | -3.66 | -1.82 | -1.85 | -10.25 | -1.87 | -2.52 | 3.65 | |
| % of Revenue | 28.74 | 30.81 | 27.26 | 24.90 | 23.50 | 22.32 | 22.18 | 22.04 | 22.19 | 22.35 | 24.88 | 28.17 | 29.64 | 31.19 | 31.33 | 33.76 |
| R&D | ||||||||||||||||
| Change (%) | ||||||||||||||||
| % of Revenue | ||||||||||||||||
| OpEx | 43 | 42 | 47 | 51 | 55 | 58 | 60 | 62 | 62 | 62 | 57 | 51 | 42 | 41 | 41 | 41 |
| Change (%) | -1.60 | 9.93 | 9.03 | 7.55 | 7.02 | 3.09 | 2.99 | -0.28 | -0.28 | -8.27 | -9.01 | -17.96 | -3.98 | 1.07 | 0.55 | |
| % of Revenue | 119.77 | 119.54 | 105.02 | 95.36 | 93.70 | 92.30 | 95.04 | 97.77 | 101.74 | 106.08 | 110.29 | 115.79 | 111.36 | 114.67 | 119.40 | 124.81 |
| Operating Income | -7 | -7 | -2 | 2 | 4 | 5 | 3 | 1 | -1 | -4 | -5 | -7 | -4 | -5 | -7 | -8 |
| Change (%) | -2.54 | -67.82 | -210.78 | 48.72 | 32.76 | -35.49 | -55.02 | -174.97 | 233.39 | 49.35 | 33.04 | -38.63 | 20.40 | 28.36 | 23.02 | |
| % of Revenue | -19.77 | -19.54 | -5.02 | 4.64 | 6.30 | 7.70 | 4.96 | 2.23 | -1.74 | -6.08 | -10.29 | -15.79 | -11.36 | -14.67 | -19.40 | -24.81 |
| Interest Expense | -5 | -5 | -4 | -3 | -4 | -4 | -5 | -5 | -6 | -6 | -6 | -5 | -5 | -5 | -5 | -4 |
| Change (%) | -4.05 | -12.32 | -14.05 | 12.48 | 11.10 | 10.69 | 9.66 | 5.99 | 5.65 | -4.81 | -5.05 | -9.86 | -3.49 | 9.18 | -12.95 | |
| % of Revenue | -13.44 | -13.08 | -9.17 | -6.56 | -6.74 | -6.90 | -7.62 | -8.35 | -9.24 | -10.20 | -11.01 | -12.06 | -12.74 | -13.19 | -14.83 | -13.42 |
| Net Income | -12 | -13 | -8 | -4 | -2 | -0 | -2 | -4 | -7 | -10 | -12 | -14 | -9 | -9 | -11 | -12 |
| Change (%) | 5.84 | -35.85 | -55.89 | -47.34 | -89.91 | 1,019.35 | 91.07 | 69.25 | 40.92 | 18.95 | 15.93 | -34.88 | 2.69 | 14.78 | 12.88 | |
| % of Revenue | -34.09 | -36.60 | -18.76 | -6.89 | -3.32 | -0.31 | -3.44 | -6.57 | -11.60 | -17.09 | -23.04 | -30.83 | -23.53 | -25.91 | -30.64 | -35.96 |
Source: Capital IQ
